Solius Labs, the world’s only Personalized Sunlight company, today announced that Solius Pro, the only FDA-cleared personalized UVB light therapy device has been named to Fast Company’s Next Big Things in Tech in the Wellness and Fitness category. The annual list recognizes breakthrough technologies with the potential to transform industries and shape the future.
Solius Pro uses a patent-pending skin analysis system to measure each user’s skin tone and calculate a precise, personalized UVB dose. It delivers the benefits of sunlight in about five minutes per week with 99% less UV risk than the sun. The device is engineered to deliver 12 times the UVB benefit of natural sunlight per minute, and in a clinical trial, users’ serum vitamin D levels rose by an average of 76% (10.2 ng/mL).
The benefits of UVB light go well beyond vitamin D. A growing body of research links UVB exposure to effects throughout the body, including bone health, immune function, mood, hormonal balance, and the gut microbiome. Solius Pro was built to deliver UVB light safely, precisely, and year-round.
“Being named to Fast Company’s Next Big Things in Tech validates what we set out to build – a way to deliver the benefits of sunlight personalized to your skin tone and needs, backed by clinical evidence and cleared by the FDA,” said Chris Kiple, Chief Executive Officer of Solius Labs. “Solius Pro represents an entirely new category of medical device designed to optimize health and longevity. Sunlight is a foundational pillar of human health, and we are excited to bring the clinical benefits of light medicine to more people, precisely and personalized.”
Fast Company’s Next Big Things in Tech recognizes innovative technologies developed by established companies, startups, and research teams that are making meaningful progress toward transforming the lives of consumers, businesses, and society. This year’s honorees span industries, with each innovation demonstrating the potential to create significant impact in the years ahead.
Solius Labs is the world’s first Personalized Sunlight company, developing FDA-cleared, medical-grade UVB light therapy technologies that safely replicate the systemic biological benefits of sunlight year-round. By combining a targeted UVB spectrum, personalized dosing, and clinical validation, Solius is redefining how UVB light is used to support human health. For more information, visit Solius.com.
About Fast Company
Fast Company is the only media brand fully dedicated to the vital intersection of business, innovation, and design, engaging the most influential leaders, companies, and thinkers on the future of business. Headquartered in New York City, Fast Company is published by Mansueto Ventures LLC, along with fellow business publication Inc. For more information, please visit fastcompany.com.
